Cubist Systematic Strategies LLC Reduces Stake in Enhabit, Inc. (NYSE:EHAB)

Cubist Systematic Strategies LLC reduced its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 40.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 87,150 shares of the company's stock after selling 58,814 shares during the period. Cubist Systematic Strategies LLC owned approximately 0.17% of Enhabit worth $681,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in shares of Enhabit by 37.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after buying an additional 83,707 shares during the last quarter. Paradice Investment Management LLC boosted its stake in shares of Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock worth $13,903,000 after buying an additional 201,997 shares during the last quarter. Corient Private Wealth LLC purchased a new position in shares of Enhabit in the 4th quarter worth $79,000. Rhumbline Advisers boosted its stake in shares of Enhabit by 2.8% in the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after buying an additional 2,211 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of Enhabit in the 4th quarter worth $124,000.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Price Performance

NYSE EHAB opened at $10.76 on Friday. The company has a market capitalization of $544.85 million, a PE ratio of -4.64 and a beta of 1.61. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The business's fifty day moving average is $8.49 and its 200 day moving average is $8.17. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. The firm had revenue of $259.90 million during the quarter, compared to analyst estimates of $266.11 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. Sell-side analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.